Mary T Szela's Net Worth
Estimate Recalculated Nov 1, 2024 10:29AM EST
Who is Mary T Szela
Mary T Szela has an estimated net worth of $19.1 Million. This is based on reported shares across multiple companies, which include ABBOTT LABORATORIES, Prometheus Biosciences, Inc., Receptos, Inc., Omega Therapeutics, Inc., Kura Oncology, Inc., Coherus BioSciences, Inc., QLT INC/BC, ALIMERA SCIENCES INC, Aegerion Pharmaceuticals, Inc., and TriSalus Life Sciences, Inc..
SEC CIK
Mary T Szela's CIK is 0001410289
Past Insider Trading and Trends
2008 was Mary T Szela's most active year for acquiring shares with 21 total transactions. Mary T Szela's most active month to acquire stocks was the month of January. 2011 was Mary T Szela's most active year for disposing of shares, totalling 38 transactions. Mary T Szela's most active month to dispose stocks was the month of November. 2011 saw Mary T Szela paying a total of $3,620,938.73 for 122,561 shares, this is the most they've acquired in one year. In 2015 Mary T Szela cashed out on 26,200 shares for a total of $3,619,376.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
